BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32561252)

  • 1. Polymorphism of TNFRSF1 A may act as a predictor of severe radiation-induced oral mucositis and a prognosis factor in patients with head and neck cancer.
    Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Gołębiowski P; Korzeb D; Rahnama-Hezavah M; Małecka-Massalska T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):283-291.e2. PubMed ID: 32561252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer.
    Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Gołębiowski P; Sobieszek G; Małecka-Massalska T
    Support Care Cancer; 2020 Feb; 28(2):531-540. PubMed ID: 31076897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
    Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
    Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of regulatory region of APEH gene (c.-521G>C, rs4855883) as a relevant predictive factor for radiotherapy induced oral mucositis and overall survival in head neck cancer patients.
    Brzozowska A; Mlak R; Homa-Mlak I; Gołębiowski P; Mazurek M; Ciesielka M; Małecka-Massalska T
    Oncotarget; 2018 Jul; 9(51):29644-29653. PubMed ID: 30038710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients.
    Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Małecka-Massalska T
    Cancer Biomark; 2018; 22(4):657-667. PubMed ID: 29865035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
    Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of hydration assessed by bioelectrical impedance analysis: a valuable predictive factor for radiation-induced oral mucositis in head and neck cancer patients.
    Brzozowska A; Mlak R; Gołębiowski P; Małecka-Massalska T
    Clin Transl Oncol; 2019 May; 21(5):615-620. PubMed ID: 30327938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of regulatory region of GHRL gene (-2531C>T) as a promising predictive factor for radiotherapy-induced oral mucositis in patients with head neck cancer.
    Brzozowska A; Homa-Mlak I; Mlak R; Gołębiowski P; Mazurek M; Ciesielka M; Małecka-Massalska T
    Head Neck; 2018 Aug; 40(8):1799-1811. PubMed ID: 29566446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between TNF-α -1031T/C gene polymorphism, plasma level of TNF-α, and risk of cachexia in head and neck cancer patients.
    Powrózek T; Mlak R; Brzozowska A; Mazurek M; Gołębiowski P; Małecka-Massalska T
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1423-1434. PubMed ID: 29802455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
    Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
    Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study.
    Schaller AKCS; Peterson A; Bäckryd E
    Scand J Pain; 2021 Apr; 21(2):256-265. PubMed ID: 34387952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
    Elting LS; Cooksley CD; Chambers MS; Garden AS
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer.
    Fleckenstein J; Kühne M; Seegmüller K; Derschang S; Melchior P; Gräber S; Fricke A; Rübe CE; Rübe C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1465-72. PubMed ID: 20947264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy.
    Homa-Mlak I; Brzozowska A; Mlak R; Szudy-Szczyrek A; Małecka-Massalska T
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Honey-Lemon Spray Versus Benzydamine Hydrochloride Spray on Radiation-Induced Acute Oral Mucositis in Head and Neck Cancer Patients: A Pilot, Randomized, Double-Blind, Active-Controlled Clinical Trial.
    Ameri A; Poshtmahi S; Heydarirad G; Cramer H; Choopani R; Hajimehdipoor H; Azghandi S; Pasalar M
    J Altern Complement Med; 2021 Mar; 27(3):255-262. PubMed ID: 33512251
    [No Abstract]   [Full Text] [Related]  

  • 16. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial.
    Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Guddattu V
    J Photochem Photobiol B; 2015 Mar; 144():51-6. PubMed ID: 25704314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
    Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis.
    Li P; Du CR; Xu WC; Shi ZL; Zhang Q; Li ZB; Fu S
    Radiat Oncol; 2013 Jun; 8():155. PubMed ID: 23803252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the whole saliva baseline proteome profile associated with development of oral mucositis in head and neck cancer patients undergoing radiotherapy.
    Jehmlich N; Stegmaier P; Golatowski C; Salazar MG; Rischke C; Henke M; Völker U
    J Proteomics; 2015 Jul; 125():98-103. PubMed ID: 25997676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.